XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
7 Months Ended 10 Months Ended 12 Months Ended
Dec. 31, 2020
Oct. 22, 2020
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Revenues $ 31,552 $ 59,765 $ 155,011 $ 145,578
Cost of revenues 22,877 46,755 112,018 111,510
Gross margin 8,675 13,010 42,993 34,068
Operating expenses:        
Selling, general and administrative 7,909 7,632 84,775 106,507
Research and development 530 85 8,393 6,033
Restructuring charges 0 0 4,203 0
Transaction expenses 10,091 0 2,605 0
Goodwill impairment 0 0 53,544 0
Operating (loss) income (9,855) 5,293 (110,527) (78,472)
Interest expense 616 1 14,436 7,762
Net (decrease) increase in fair value of derivatives 0 0 (1,591) 33,353
Loss on extinguishment of debt 0 0 0 2,881
Other expense 0 19 0
(Loss) income before taxes (10,471) 5,292 (123,391) (122,468)
Income tax (benefit) expense (2,633) 3 (1,717) 1,084
Net (loss) income $ (7,838) $ 5,289 $ (121,674) $ (123,552)
Basic net loss per share (in usd per share) $ (0.07)   $ (0.95) $ (1.15)
Diluted net loss per share (in usd per share) $ (0.07)   $ (0.95) $ (1.15)
Weighted-average shares outstanding:        
Weighted-average shares outstanding, Basic (in shares) 105,000,000   127,698,478 107,009,834
Weighted-average shares outstanding, Diluted (in shares) 105,000,000   127,698,478 107,009,834